Ryan in other questions

Wearables the focus. Ian chief operating officer. 11o plus employees let go.

Reading between the lines it appears the Unifill, Autoinjector ocular may be spun off or curtailed.

That begs the question of the status of those supply agreements, programs.

Is Sanofi PFS dead?

Hikma dead?

Ocular dead?

AbbVie Dead.

Or operating efficiency so advanced that company can operate with 50% plus less resources.

It lends the question on all the construction investments made over the last two years where did it go for what?

Seeking clarity on events the past few years with capital and programs.

Waiting to see the reaction today on the street.

RRM